Journal profile · PHARMACOLOGY & PHARMACY
Annales Pharmaceutiques Francaises
ISSN 0003-4509 · eISSN 2772-803X · Elsevier
Annales Pharmaceutiques Francaises: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.3 (journal website); subscription journal; APC about USD 3,000; median 94 days to acceptance (105 articles, last 24 months); acceptance rate 16% (journal website); 122 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Annales Pharmaceutiques Francaises is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Health, Medicine and Society and Healthcare Systems and Practices, together about 27.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Sous l'égide de l'Académie Nationale de PharmacieAnnales pharmaceutiques françaises proposes a scientific information validated and indexed to be informed about the last research works in all the domains interesting the pharmacy. The original works, general reviews, the focusing, the brief notes, subjected by the best academics and the professionals, propose a synthetic approach of the last progress accomplished in the concerned sectors. The thematic Sessions and the "life of the Academy" resume the communications which, presented in front of the national Academy of pharmacy, are in the heart of the current events. The analyses of the theses and the works, the comments of articles and the questions of current events offer an alive and interactive outline of the last news to keep posted real time about the evolution of the knowledge useful for the pharmacist. The content of the published articles is the sole responsibility of the authors and does not necessarily reflect the positions of the French National Academy of Pharmacy.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Alain ASTIERPublisher website
Editorial board by country: none in mainland China; most named France 12 (12 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine11%
- Health, Medicine and SocietyHealth Professions8.4%
- Healthcare Systems and PracticesHealth Professions7.8%
- Human auditory perception and evaluationEngineering6.2%
- Educational Robotics and EngineeringComputer Science6.2%
- Safe Handling of Antineoplastic DrugsHealth Professions6.1%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.1%
- Pharmaceutical studies and practicesMedicine4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.3Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- CiteScore (publisher)
- 2.4Publisher website ·
- SJR 2026-06
- 0.28LetPub ·
- SNIP 2026-06
- 0.59LetPub ·
- h-index
- 37OpenAlex ·
- i10-index
- 235OpenAlex ·
- 2-year mean citedness
- 1.53OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 1.62%LetPub ·
Volume
- Articles per year
- 111LetPub ·
Articles by year OpenAlex count · 1,890 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 89 | 5 | 24 |
| 2025 | 122 | 5 | 167 |
| 2024 | 125 | 31 | 324 |
| 2023 | 86 | 30 | 323 |
| 2022 | 98 | 42 | 433 |
| 2021 | 109 | 39 | 484 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
94 daysMedian, submission to acceptance · P25–P75 64 days – 129 days
- Acceptance to online
- median 3 days (105 articles)
- Submission to online
- median 97 days
- Sample
- 105 articles with submission and acceptance dates (250 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 16%Publisher website ·
- Submission to acceptance
- 87 daysPublisher website ·
- Acceptance to publication
- 4 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 0003-4509
- Electronic ISSN
- 2772-803X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Annales Pharmaceutiques Francaises
What CAS zone is Annales Pharmaceutiques Francaises in?
In the 2025 upgraded edition of the CAS Journal Ranking, Annales Pharmaceutiques Francaises is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Annales Pharmaceutiques Francaises?
The journal's website gives an impact factor of 1.3; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.4, h-index 37.
How long does peer review take at Annales Pharmaceutiques Francaises?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 94 days (interquartile range 64–129 days); the journal's website gives an acceptance rate of 16%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Annales Pharmaceutiques Francaises based?
Of the 12 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (12). Counted from the institutions listed on the board page; for reference only.
Which databases index Annales Pharmaceutiques Francaises?
According to LetPub and DOAJ records, Annales Pharmaceutiques Francaises is indexed in ESCI and Scopus.
Is Annales Pharmaceutiques Francaises open access, and what is the APC?
Annales Pharmaceutiques Francaises is a subscription journal. APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .